Celltrion Announces Positive Pre-clinical Results for COVID- 19 Antiviral Antibody Treatment Read more
Roche initiates phase III clinical trial of Actemra/RoActemra plus remdesivir in hospitalised patients with severe COVID-19 pneumonia Read more
Lonza and Sanquin Partner for Commercialization of Specialized MAT Reagents for Accurate and Reliable in vitro Pyrogen Testing Read more
Bird Rock Bio Files IND Application for Phase 2 Study of Nimacimab for Treatment of Renal Diseases Read more
IRBM’s Advent announces manufacture of 13,000 doses of Covid-19 vaccine, for use in Phase 2/3 clinical trials by the University of Oxford Read more